Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

NIH-funded research enhances genetic testing for health equity

NIH-funded research enhances genetic testing for health equity

Selection, optimization, and validation of genetic tests for 10 common diseases

Selection, optimization, and validation of genetic tests for 10 common diseases

What factors are associated with recent prostate-specific antigen screening in transgender women?

What factors are associated with recent prostate-specific antigen screening in transgender women?

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

Representation matters to Black patients seeking prostate cancer information online, study shows

Representation matters to Black patients seeking prostate cancer information online, study shows

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Wayne State researchers secure $1.4 million DoD grant for prostate cancer study

Wayne State researchers secure $1.4 million DoD grant for prostate cancer study

Reducing unnecessary testing or treatments in older patients

Reducing unnecessary testing or treatments in older patients

New prostate cancer resource helps to better understand treatment options and outcomes

New prostate cancer resource helps to better understand treatment options and outcomes

Boosting fitness levels linked to lower prostate cancer risk

Boosting fitness levels linked to lower prostate cancer risk

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Long-term prostate cancer treatment study informs decisions for diverse groups

Long-term prostate cancer treatment study informs decisions for diverse groups

Team approach to prostate cancer: PCPs and urologists offer hope with active surveillance

Team approach to prostate cancer: PCPs and urologists offer hope with active surveillance

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.